June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com
Editor-in-Chief: Aviva Lev-Ari, PhD, RN
6/19/2016 @8:30PM EST
PRESS RELEASE 6/20/2016
ReleaseWire – Leaders in Pharmaceutical Business Intelligence (LBPI Group), launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), has reached over 1 million unique site visits, with approximately 30,000 monthly views, 1,600 followers and 300 sites linking into the journal, including ncbi.nlm.nih.gov, Nature.com , commons.wikipedia.org, dx.doi.org, NEJM, personalizedmedicine.partners.org, cancer.gov, medscape.com, masspec.scripps.edu, and sciencedirect.com.
Leaders in Pharmaceutical Business Intelligence Group is a scientific, medical and business multi-expert authoring platform in several domains: life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at its website http://pharmaceuticalintelligence.com for curation and reporting on innovations in biomedical and biological sciences, healthcare economics, pharmacology, pharmaceutical research & medicine. The Open Access Online Scientific Journal currently contains 2,521 annotated & curated articles in over 300 categories of research in Biotech, Life Sciences and Medicine.
The LBPI Group venture publishes a BioMedical Series of e-Books available on mobile platforms (current & future titles at https://pharmaceuticalintelligence.com/biomed-e-books/.) It also represents a dozen Biotechnology and Medical Devices startups in Private Equity Funding and an IP Development Group, DrugDiscovery@LPBI Group, and Medical 3D Printing.
The venture’s expertise in Real-Time Scientific Conferences Coverage, using social media and creating electronic conference proceedings posted on the Internet, has included the following events as well as others: Harvard’s Personalized Medicine Conferences in 2015 & 2016, CHI Discovery On Target 2016, MassBio 2015 & 2016, MassBioAnnual Meeting 2014, BioIT World, April 30, 2014, Koch Institute for Integrative Cancer Research @MIT – Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014, Gabbay Award Lectures in Biotechnology and Medicine – Hosted by Rosenstiel Basic Medical Sciences Research Center, Brandeis University, October 27, 2014, 10th Annual Personalized Medicine Conference at the Harvard Medical School, November 12-13, 2014, and two Biotech Investment Conferences in 2014, one in NYC and one in Basel by Sachs Associates of London.
Media Relations Contact
4,716 Scientific Articles
487 Research Categories in Life Sciences & Medicine
9,286 Scientific Tags
7,251 Scientific Comments
Followers (includes Publicize)
2,116 e-Journal Subscribers
Our DOMAINS in e-Scientific Media
I. Pharmaceutical: Biologics, Small Molecules, Diagnostics
II. Life Sciences: Genomics and Cancer Biology
III. Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology
IV. Biomedicine, BioTech, and MedTech (Medical Devices)
V. HealthCare: Patient-centered Medicine and Personalized/Precision Medicine
Open Access Online Journal
is a scientific, medical and business, multi-expert authoring environment for information syndication in several domains of Life Sciences, Medicine, Pharmaceutical and Healthcare Industries, BioMedicine, Medical Technologies & Devices. Scientific critical interpretations and original articles are written by PhDs, MDs, MD/PhDs, PharmDs, Technical MBAs as Experts, Authors, Writers (EAWs) on an Equity Sharing basis.
All articles in the Journal are written by Experts, Authors, Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation.
Articles that have been published on the Open Access Online Scientific Journal, since April 2012 are selected by Domain Expert Editors for creation of original electronic Table of Contents (eTOCs).
|Author||Views on 7/6/2016|
|Aviva Lev-Ari, PhD, RN||274,480|
|Dr. Sudipta Saha||18,540|
|Demet Sag, Ph.D., CRA, GCP||10,937|
|Alan F. Kaul, PharmD., MS, MBA, FCCP||1,894|
|Aashir Awan, Phd||1,706|
See Our e-Books on Amazon.com
LPBI Group has Three Enterprise Types and Five Subsidiaries
We are in Knowledge-based Informational Services
Subsidiary 1: e-Scientific Content Creation and Digital Media
Open Access OnLine Scientific Journal +1 Million e-Readers on 6/19/2016, 2,116 Subscribers, 4,716 Scientific Articles, ~7,251 Comments by Scientists
BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 7 e-Books in 2016
Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events
Audio-Podcast Series in Medicine, 5 tracks
Subsidiary 4: Intellectual Property Asset Management
We are in Research Biotech Businesses
Subsidiary 3: R&D in 3D BioPrinting
Subsidiary 5: Pharmaceutical R&D: Drug Discovery and Drug-Devices Development
We are in Business Financial Transactions (No Securities Traded)
Subsidiary 2: Funding Early Stage Businesses, IP Licensing and Business Partnerships:
Corporate Clients for Our Services
- MEDICAL DEVICES
- Pharmaceutical Informational PLATFORMS
- INVENTIONS IN BIOLOGICS